It is interesting that in an animal model with overexpressed adropin, a high-fat diet did not demonstrate the clinical manifestation of obesity and glucose imbalance [137,138], which was explained by the beneficial effect of adropin on sensitization of insulin signaling pathways, and improved glucose metabolism. The gene discussed is ENHO; the disease is obesity due to melanocortin 4 receptor deficiency.